Clinical Trials in Atlanta

Showing 16921-16940 of 19,805 trials

Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.

NCT00209144

The purpose of this study is to determine if intense control of high glucose levels in patients treated with angioplasty for heart attack has anti-inflammatory and anti-thrombotic effects.

Acute Myocardial Infarction

Emory University58 participantsStarted Oct 2004

Atlanta, Georgia, United States • Atlanta, Georgia, United States

COMPLETEDPhase 3< 1 mile

Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)

NCT00400153

The primary objective of this study is to compare the effect of ipratropium bromide/salbutamol inhalation spray combination administered by the Respimat® inhaler (20 mcg/100 mcg), ipratropium bromide inhalation spray administered by the Respimat® inhaler (20 mcg), and COMBIVENT® MDI administered q.i.d on FEV1 at intervals over a treatment period of 12 weeks in patients with COPD. Specifically, non-inferiority of Combivent Respimat® to COMBIVENT® MDI in FEV1 AUC from 0 to 6 hours , superiority of Combivent Respimat® to Atrovent Respimat® monotherapy in FEV1 AUC from 0 to 4 hours, and non-inferiority of Combivent Respimat® to Atrovent Respimat® monotherapy in FEV1 AUC from 4 to 6 hours will be analyzed. In addition, steady state pharmacokinetics over one dosing interval following 4 weeks of therapy will be characterized in a subgroup of patients.

Pulmonary Disease, Chronic Obstructive

Boehringer Ingelheim1,480 participantsStarted Nov 2006

Birmingham, Alabama, United States • Jasper, Alabama, United States • Mobile, Alabama, United States +177 more locations

Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.

Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)

Find Trials by Condition in Atlanta

A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).

Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes

Dapagliflozin DPPIV Inhibitor add-on Study

Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension

Dose Range Finding Study of Fedovapagon in Men With Nocturia

AST-120 Used to Treat Mild Hepatic Encephalopathy

Treatment for Presumed Ocular Histoplasmosis

Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome

Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia

Comparison of Ipilimumab Manufactured by 2 Different Processes in Participants With Advanced Melanoma

Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device

A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder

Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV

A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma

Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors